The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
How to manage Pseudomonas aeruginosa infections
Open accessAbstract
This review looks at the mechanisms associated with resistance to Pseudomonas aeruginosa, as well as antibiotic combinations and limitations of current therapies, and the potential for alternative drugs and new therapeutic options are also discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mandell, L. A., Wunderink, R. G., Anzueto, A., Bartlett, J. G., Campbell, G. D., Dean, N. C., Dowell, S. F., File, T. M., Musher, D. M., Niederman, M. S., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/511159 · Cited by 6,202
Multistate point-prevalence survey of health care-associated infections
Magill, S. S., Edwards, J. R., Bamberg, W., Beldavs, Z. G., Dumyati, G., Kainer, M. A., Lynfield, R., Maloney, M., McAllister-Hollod, L., Nadle, J., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1306801 · Cited by 3,931
Kalil, A. C., Metersky, M. L., Klompas, M., Muscedere, J., Sweeney, D. A., Palmer, L. B., Napolitano, L. M., O'Grady, N. P., Bartlett, J. G., Carratalà, J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw353 · Cited by 3,892
Stevens, D. L., Bisno, A. L., Chambers, H. F., Dellinger, E. P., Goldstein, E. J. C., Gorbach, S. L., Hirschmann, J. V., Kaplan, S. L., Montoya, J. G., & Wade, J. C. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu296 · Cited by 2,780
Bradford, P. A. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.933-951.2001 · Cited by 2,618
A functional classification scheme for beta-lactamases and its correlation with molecular structure
Bush, K., Jacoby, G. A., & Medeiros, A. A. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.6.1211 · Cited by 2,475
Lister, P. D., Wolter, D. J., & Hanson, N. D. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00040-09 · Cited by 1,789
Multiple Mechanisms of Antimicrobial Resistance in Pseudomonas aeruginosa: Our Worst Nightmare?
Livermore, D. M. (2002) · Clinical Infectious Diseases · doi:10.1086/338782 · Cited by 1,453
Metallo-β-Lactamases: the Quiet before the Storm?
Walsh, T. R., Toleman, M. A., Poirel, L., & Nordmann, P. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.2.306-325.2005 · Cited by 1,431
Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria
Olaitan, A. O., Morand, S., & Rolain, J.-M. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00643 · Cited by 1,395
Roberts, J. A., Paul, S. K., Akova, M., Bassetti, M., De Waele, J. J., Dimopoulos, G., Kaukonen, K.-M., Koulenti, D., Martin, C., Montravers, P., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu027 · Cited by 1,090
Self-citationEfflux-mediated antimicrobial resistance
Poole, K. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki171 · Cited by 1,082
Applications of MALDI-TOF mass spectrometry in clinical diagnostic microbiology
Croxatto, A., Prod'hom, G., & Greub, G. (2012) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00298.x · Cited by 997
Self-citationStevens, D. L., Bisno, A. L., Chambers, H. F., Dellinger, E. P., Goldstein, E. J. C., Gorbach, S. L., Hirschmann, J. V., Kaplan, S. L., Montoya, J. G., & Wade, J. C. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu444 · Cited by 988
Pseudomonas aeruginosa – a phenomenon of bacterial resistance
Strateva, T., & Yordanov, D. (2009) · Journal of Medical Microbiology · doi:10.1099/jmm.0.009142-0 · Cited by 803
Potron, A., Poirel, L., & Nordmann, P. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.03.001 · Cited by 688
Emerging carbapenemases in Gram-negative aerobes
Nordmann, P., & Poirel, L. (2002) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2002.00401.x · Cited by 684
Versatility of Aminoglycosides and Prospects for Their Future
Vakulenko, S. B., & Mobashery, S. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.3.430-450.2003 · Cited by 643
Severe Community-acquired Pneumonia: Epidemiology and Prognostic Factors
Torres, A., Serra-Batlles, J., Ferrer, A., Jiménez, P., Celis, R., Cobo, E., & Rodriguez-Roisin, R. (1991) · American Review of Respiratory Disease · doi:10.1164/ajrccm/144.2.312 · Cited by 613
Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium
Mesaros, N., Nordmann, P., Plésiat, P., Roussel-Delvallez, M., Van Eldere, J., Glupczynski, Y., Van Laethem, Y., Jacobs, F., Lebecque, P., Malfroot, A., et al. (2007) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01681.x · Cited by 585
16S Ribosomal RNA Methylation: Emerging Resistance Mechanism against Aminoglycosides
Doi, Y., & Arakawa, Y. (2007) · Clinical Infectious Diseases · doi:10.1086/518605 · Cited by 571
Kang, C., Kim, S., Kim, H., Park, S., Choe, Y., Oh, M., Kim, E., & Choe, K. (2003) · Clinical Infectious Diseases · doi:10.1086/377200 · Cited by 565
Mechanisms of antibiotic resistance in Pseudomonas aeruginosa.
Lambert, P. A. (2002) · Europe PMC (PubMed Central) · Cited by 489
Aminoglycoside Resistance in Pseudomonas aeruginosa
Poole, K. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.479-487.2005 · Cited by 470
McPhee, J. B., Lewenza, S., & Hancock, R. E. W. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03673.x · Cited by 443
Torres, A., Zhong, N., Pachl, J., Timsit, J.-F., Kollef, M., Chen, Z., Song, J., Taylor, D., Laud, P. J., Stone, G. G., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30747-8 · Cited by 441
Solomkin, J., Hershberger, E., Miller, B., Popejoy, M., Friedland, I., Steenbergen, J., Yoon, M., Collins, S., Yuan, G., Barie, P. S., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ097 · Cited by 420
Mechanisms of Action and Resistance of Older and Newer Fluoroquinolones
Hooper, D. C. (2000) · Clinical Infectious Diseases · doi:10.1086/314056 · Cited by 409
Arancibia, F., Bauer, T. T., Ewig, S., Mensa, J., Gonzalez, J., Niederman, M. S., & Torres, A. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.16.1849 · Cited by 401
Nosocomial pneumonia in 27 ICUs in Europe: perspectives from the EU-VAP/CAP study
Koulenti, D., Tsigou, E., & Rello, J. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-016-2703-z · Cited by 392
Of Pseudomonas, porins, pumps and carbapenems
Livermore, D. M. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/47.3.247 · Cited by 391
The leading causes of death after burn injury in a single pediatric burn center
Williams, F. N., Herndon, D. N., Hawkins, H. K., Lee, J. O., Cox, R. A., Kulp, G. A., Finnerty, C. C., Chinkes, D. L., & Jeschke, M. G. (2009) · Critical Care · doi:10.1186/cc8170 · Cited by 375
Zhanel, G. G., Chung, P., Adam, H., Zelenitsky, S., Denisuik, A., Schweizer, F., Lagacé-Wiens, P. R. S., Rubinstein, E., Gin, A. S., Walkty, A., et al. (2014) · Drugs · doi:10.1007/s40265-013-0168-2 · Cited by 340
Norbury, W., Herndon, D. N., Tanksley, J., Jeschke, M. G., Finnerty, C. C., & on Behalf of the Scientific Study Committee of the Surgical Infection Society (2016) · Surgical Infections · doi:10.1089/sur.2013.134 · Cited by 337
Vardakas, K. Z., Voulgaris, G. L., Maliaros, A., Samonis, G., & Falagas, M. E. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30615-1 · Cited by 327
Fernández, L., Gooderham, W. J., Bains, M., McPhee, J. B., Wiegand, I., & Hancock, R. E. W. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00242-10 · Cited by 320
The Epidemiology of Burn Wound Infections: Then and Now
Weinstein, R. A., & Mayhall, C. G. (2003) · Clinical Infectious Diseases · doi:10.1086/376993 · Cited by 313
Emerging Technologies for the Clinical Microbiology Laboratory
Buchan, B. W., & Ledeboer, N. A. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00003-14 · Cited by 297
Villegas, M. V., Lolans, K., Correa, A., Kattan, J. N., Lopez, J. A., & Quinn, J. P. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01405-06 · Cited by 293
Haidar, G., Philips, N. J., Shields, R. K., Snyder, D., Cheng, S., Potoski, B. A., Doi, Y., Hao, B., Press, E. G., Cooper, V. S., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix182 · Cited by 277
Garnacho-Montero, J., Sa-Borges, M., Sole-Violan, J., Barcenilla, F., Escoresca-Ortega, A., Ochoa, M., Cayuela, A., & Rello, J. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000275389.31974.22 · Cited by 275
Köhler, T., Michea-Hamzehpour, M., Epp, S. F., & Pechere, J.-C. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.2.424 · Cited by 268
Micek, S. T., Wunderink, R. G., Kollef, M. H., Chen, C., Rello, J., Chastre, J., Antonelli, M., Welte, T., Clair, B., Ostermann, H., et al. (2015) · Critical Care · doi:10.1186/s13054-015-0926-5 · Cited by 267
Wright, H., Bonomo, R. A., & Paterson, D. L. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.09.001 · Cited by 256
Macfarlane, E. L. A., Kwasnicka, A., Ochs, M. M., & Hancock, R. E. W. (1999) · Molecular Microbiology · doi:10.1046/j.1365-2958.1999.01600.x · Cited by 254
Barrasa-Villar, J. I., Aibar-Remón, C., Prieto-Andrés, P., Mareca-Doñate, R., & Moliner-Lahoz, J. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix411 · Cited by 238
Miller, G. H., Sabatelli, F. J., Hare, R. S., Glupczynski, Y., Mackey, P., Shlaes, D., Shimizu, K., Shaw, K. J., & Groups, A. R. S. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.supplement_1.s46 · Cited by 235
Cross-resistance to meropenem, cephems, and quinolones in Pseudomonas aeruginosa
Masuda, N., & Ohya, S. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.9.1847 · Cited by 215
Macfarlane, E. L. A., Kwasnicka, A., & Hancock, R. E. W. (2000) · Microbiology · doi:10.1099/00221287-146-10-2543 · Cited by 209
Twenty-five year review ofPseudomonas aeruginosa bacteremia in a burn center
McManus, A. T., Mason, A. D., McManus, W. F., & Pruitt, B. A. (1985) · European Journal of Clinical Microbiology · doi:10.1007/bf02013601 · Cited by 204
Girlich, D., Naas, T., & Nordmann, P. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.6.2043-2048.2004 · Cited by 201
Microbiology of Ventilator–Associated Pneumonia Compared With That of Hospital-Acquired Pneumonia
Weber, D. J., Rutala, W. A., Sickbert-Bennett, E. E., Samsa, G. P., Brown, V., & Niederman, M. S. (2007) · Infection Control & Hospital Epidemiology · doi:10.1086/518460 · Cited by 186
Gram Negative Wound Infection in Hospitalised Adult Burn Patients-Systematic Review and Metanalysis-
Azzopardi, E. A., Azzopardi, E., Camilleri, L., Villapalos, J., Boyce, D. E., Dziewulski, P., Dickson, W. A., & Whitaker, I. S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095042 · Cited by 183
Lucasti, C., Vasile, L., Sandesc, D., Venskutonis, D., McLeroth, P., Lala, M., Rizk, M. L., Brown, M. L., Losada, M. C., Pedley, A., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00633-16 · Cited by 182
Activity of Imipenem with Relebactam against Gram-Negative Pathogens from New York City
Lapuebla, A., Abdallah, M., Olafisoye, O., Cortes, C., Urban, C., Landman, D., & Quale, J. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00830-15 · Cited by 181
Bert, F. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf069 · Cited by 180
Severe community-acquired pneumonia: assessment of microbial aetiology as mortality factor
Paganin, F., Lilienthal, F., Bourdin, A., Lugagne, N., Tixier, F., Génin, R., & Yvin, J.-L. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00119503 · Cited by 173
Aktaş, Z., Kayacan, C., & Oncul, O. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.09.012 · Cited by 169
El Zowalaty, M. E., Al Thani, A. A., Webster, T. J., El Zowalaty, A. E., Schweizer, H. P., Nasrallah, G. K., Marei, H. E., & Ashour, H. M. (2015) · Future Microbiology · doi:10.2217/fmb.15.48 · Cited by 169
Discovery of MK-7655, a β-lactamase inhibitor for combination with Primaxin®
Blizzard, T. A., Chen, H., Kim, S., Wu, J., Bodner, R., Gude, C., Imbriglio, J., Young, K., Park, Y.-W., Ogawa, A., et al. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.12.101 · Cited by 168
Thaden, J. T., Park, L. P., Maskarinec, S. A., Ruffin, F., Fowler, V. G., & van Duin, D. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02671-16 · Cited by 168
Llano-Sotelo, B., Azucena, E. F., Kotra, L. P., Mobashery, S., & Chow, C. S. (2002) · Chemistry & Biology · doi:10.1016/s1074-5521(02)00125-4 · Cited by 167
Microbiological Testing and Outcome of Patients With Severe Community-Acquired Pneumonia
Rello, J., Bodi, M., Mariscal, D., Navarro, M., Diaz, E., Gallego, M., & Valles, J. (2003) · Chest · doi:10.1378/chest.123.1.174 · Cited by 167
Sims, M., Mariyanovski, V., McLeroth, P., Akers, W., Lee, Y.-C., Brown, M. L., Du, J., Pedley, A., Kartsonis, N. A., & Paschke, A. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx139 · Cited by 166
Lund-Palau, H., Turnbull, A. R., Bush, A., Bardin, E., Cameron, L., Soren, O., Wierre-Gore, N., Alton, E. W. F. W., Bundy, J. G., Connett, G., et al. (2016) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2016.1177460 · Cited by 165
Peña, C., Suarez, C., Ocampo-Sosa, A., Murillas, J., Almirante, B., Pomar, V., Aguilar, M., Granados, A., Calbo, E., Rodríguez-Baño, J., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit223 · Cited by 164
Characterization of the Polymyxin B Resistome of Pseudomonas aeruginosa
Fernández, L., Alvarez‐Ortega, C., Wiegand, I., Olivares‐Pacheco, J., Kocíncová, D., Lam, J. S., Martínez, J. L., & Hancock, R. E. W. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01583-12 · Cited by 155
Rapidec Carba NP Test for Rapid Detection of Carbapenemase Producers
Poirel, L., & Nordmann, P. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.00977-15 · Cited by 153
Extended-spectrum beta-lactamases in Pseudomonas aeruginosa
Nordmann, P. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/42.2.128 · Cited by 144
Lees, C. W., Heys, D., Ho, G., Noble, C. L., Shand, A. G., Mowat, C., Boulton-Jones, R., WILLIAMS, A., Church, N. G., Satsangi, J., et al. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03383.x · Cited by 140
Thaden, J. T., Pogue, J. M., & Kaye, K. S. (2016) · Virulence · doi:10.1080/21505594.2016.1207834 · Cited by 134
The emergence and implications of metallo-β-lactamases in Gram-negative bacteria
Walsh, T. R. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01264.x · Cited by 131
Gutu, A. D., Sgambati, N., Strasbourger, P., Brannon, M. K., Jacobs, M. A., Haugen, E., Kaul, R., Johansen, H. K., Høiby, N., & Moskowitz, S. M. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02353-12 · Cited by 131
Clinical Pharmacodynamics of Cefepime in Patients Infected with Pseudomonas aeruginosa
Crandon, J. L., Bulik, C. C., Kuti, J. L., & Nicolau, D. P. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01183-09 · Cited by 123
Castanheira, M., Mills, J. C., Costello, S. E., Jones, R. N., & Sader, H. S. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00163-15 · Cited by 123
Righi, E., Peri, A. M., Harris, P. N. A., Wailan, A. M., Libório, M. P., Lane, S., & Paterson, D. L. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw459 · Cited by 120
Self-citationCommunity-Acquired Pneumonia Due to Multidrug- and Non–Multidrug-Resistant Pseudomonas aeruginosa
Cillóniz, C., Gabarrús, A., Ferrer, M., de la Bellacasa, J. P., Rinaudo, M., Mensa, J., Niederman, M. S., & Torres, A. (2016) · CHEST Journal · doi:10.1016/j.chest.2016.03.042 · Cited by 118
Sligl, W., Dragan, T., & Smith, S. W. (2015) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2015.06.024 · Cited by 102
Fernández-Barat, L., Ferrer, M., De Rosa, F., Gabarrús, A., Esperatti, M., Terraneo, S., Rinaudo, M., Li Bassi, G., & Torres, A. (2017) · Journal of Infection · doi:10.1016/j.jinf.2016.11.008 · Cited by 99
Liu, Q., Li, X., Li, W., Du, X., He, J., Tao, C., & Feng, Y. (2015) · Scientific Reports · doi:10.1038/srep11715 · Cited by 84
Tobramycin penetration into epithelial lining fluid of patients with pneumonia
Carcas, A. J., GARCÍA-SATUÉ, J. L., Zapater, P., et al. (1999) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(99)70103-7 · Cited by 84
Riu, M., Chiarello, P., Terradas, R., Sala, M., García-Alzorriz, E., Castells, X., Grau, S., & Cots, F. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153076 · Cited by 65
Tofas, P., Samarkos, M., Piperaki, E., Kosmidis, C., Triantafyllopoulou, I.-D., Kotsopoulou, M., Pantazatou, A., Perlorentzou, S. P., Poulli, A., Vagia, M., et al. (2017) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2017.05.003 · Cited by 64
Severe Community-acquired Pneumonia in an Intensive Care Unit: Risk Factors for Mortality
Yoshimoto, A., Nakamura, H., Fujimura, M., & Nakao, S. (2005) · Internal Medicine · doi:10.2169/internalmedicine.44.710 · Cited by 57
Rapid detection of carbapenemase activity: benefits and weaknesses of MALDI-TOF MS
Mirande, C., Canard, I., Buffet, S., Charrier, J., van Belkum, A., Welker, M., & Chatellier, S. (2015) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-015-2473-z · Cited by 56
Venier, A.-G., Gruson, D., Lavigne, T., et al. (2011) · Journal of Hospital Infection · doi:10.1016/j.jhin.2011.05.007 · Cited by 55
Peña, C., Suarez, C., Tubau, F., Domínguez, A., Sora, M., Pujol, M., Gudiol, F., & Ariza, J. (2008) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-008-0645-9 · Cited by 51
Jeong, S. J., Yoon, S. S., Bae, I. K., Jeong, S. H., Kim, J. M., & Lee, K. (2014) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2014.07.003 · Cited by 40
Peng, Y., Bi, J., Shi, J. C., Li, Y., Ye, X., Chen, X., & Yao, Z. (2014) · American Journal of Infection Control · doi:10.1016/j.ajic.2014.08.006 · Cited by 38
Sader, H. S., Castanheira, M., Farrell, D. J., Flamm, R. K., & Jones, R. N. (2015) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2015.06.008 · Cited by 34
Dalben, M. F., Basso, M., Garcia, C. P., Costa, S. F., Toscano, C. M., Jarvis, W. R., Lobo, R., de Oliveira, M. S., & Levin, A. S. (2013) · Clinics · doi:10.6061/clinics/2013(08)11 · Cited by 33
Lévy, J., Baran, D., & Klastersky, J. A. (1982) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/10.3.227 · Cited by 26
Willmann, M., Klimek, A. M., Vogel, W., Liese, J., Marschal, M., Autenrieth, I. B., Peter, S., & Buhl, M. E. J. (2014) · BMC Infectious Diseases · doi:10.1186/s12879-014-0650-9 · Cited by 25
Cholley, P., Stojanov, M., Hocquet, D., Thouverez, M., Bertrand, X., & Blanc, D. (2015) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2015.03.027 · Cited by 23
Pseudomonas aeruginosa in French hospitals between 2001 and 2011: back to susceptibility
ONERBA, O. B. O. T., Slekovec, C., Robert, J., Trystram, D., Delarbre, J.-M., Mérens, A., Mee-Marquet, N. V. D., de Gialluly, C., Costa, Y., Caillon, J., et al. (2014) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-014-2125-8 · Cited by 14
Cited by
Epidemiology and Diagnostics of Carbapenem Resistance in Gram-negative Bacteria
Nordmann, P., & Poirel, L. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz824 · Cited by 721
The Epidemiology and Pathogenesis and Treatment of Pseudomonas aeruginosa Infections: An Update
Reynolds, D., & Kollef, M. (2021) · Drugs · doi:10.1007/s40265-021-01635-6 · Cited by 721
World Health Organization Report: Current Crisis of Antibiotic Resistance
Talebi Bezmin Abadi, A., Rizvanov, A. A., Haertlé, T., & Blatt, N. L. (2019) · BioNanoScience · doi:10.1007/s12668-019-00658-4 · Cited by 465
Shaaban, M. T., Ghaly, M. F., & Fahmi, S. M. (2021) · Journal of Basic Microbiology · doi:10.1002/jobm.202100061 · Cited by 287
Mountcastle, S. E., Vyas, N., Villapun, V. M., Cox, S. C., Jabbari, S., Sammons, R. L., Shelton, R. M., Walmsley, A. D., & Kuehne, S. A. (2021) · npj Biofilms and Microbiomes · doi:10.1038/s41522-021-00214-7 · Cited by 130
Metadata
- Authors
- Bassetti, M., Vena, A., Croxatto, A., Righi, E., & Guery, B.
- Venue
- Drugs in Context
- Publisher
- BioExcel
- Published
- 2018-05-29
- Volume
- 7
- Pages
- 1-18
- ISSN
- 1740-4398 (ISSN-L)
- OpenAlex
- W2807161463
- Cited by
- 746
- References
- 95
- FWCI
- 25.27
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.